Clinical trials
Active, not recruiting Smoldering Multiple Myeloma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 20 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dana-Farber Cancer Institute | 4 |
| City of Hope Medical Center | 2 |
| M.D. Anderson Cancer Center | 2 |
| National Cancer Institute (NCI) | 2 |
| Case Comprehensive Cancer Center | 1 |
| European Myeloma Network B.V. | 1 |
| Intergroupe Francophone du Myelome | 1 |
| International Myeloma Foundation | 1 |
| Massachusetts General Hospital | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Smoldering Multiple Myeloma | 20 |
| Multiple Myeloma | 5 |
| Monoclonal Gammopathy of Undetermined Significance | 3 |
| Neoplasms, Plasma Cell | 3 |
| Lymphoma | 1 |
| Lymphoproliferative Disorders | 1 |
| Paraproteinemias | 1 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 |
| Waldenstrom Macroglobulinemia | 1 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.